相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
J. Tong et al.
ONCOGENE (2017)
FBW7-Dependent Mcl-1 Degradation Mediates the Anticancer Effect of Hsp90 Inhibitors
Jingshan Tong et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers
A. N. Hata et al.
ONCOGENE (2017)
Combined MEK and Pi3′-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo
Oussama ElMokh et al.
ONCOTARGET (2017)
Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells
Jingshan Tong et al.
CANCER RESEARCH (2017)
Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcoma
U. Heinicke et al.
ONCOGENE (2016)
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer
Ryan B. Corcoran et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells
Gorbatchev Ambroise et al.
ONCOTARGET (2015)
Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma
Sarah J. Welsh et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road
Christopher J. Caunt et al.
NATURE REVIEWS CANCER (2015)
Regorafenib Inhibits Colorectal Tumor Growth through PUMA-Mediated Apoptosis
Dongshi Chen et al.
CLINICAL CANCER RESEARCH (2014)
The Biology and Clinical Development of MEK Inhibitors for Cancer
Jason J. Luke et al.
DRUGS (2014)
Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor
Douglas B. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The clinical development of MEK inhibitors
Yujie Zhao et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield et al.
NATURE REVIEWS CANCER (2014)
Mutations of the BRAF gene in human cancer, by Davies etal. (Nature 2002; 417: 94954)
G. W. M. Millington
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2013)
Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma
Federica Catalanotti et al.
CLINICAL CANCER RESEARCH (2013)
Crizotinib Induces PUMA-Dependent Apoptosis in Colon Cancer Cells
Xingnan Zheng et al.
MOLECULAR CANCER THERAPEUTICS (2013)
BIM, PUMA, and the Achilles' Heel of Oncogene Addiction
Anne Roulston et al.
SCIENCE SIGNALING (2013)
ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
Georgia Hatzivassiliou et al.
MOLECULAR CANCER THERAPEUTICS (2012)
PUMA-Mediated Apoptosis Drives Chemical Hepatocarcinogenesis in Mice
Wei Qiu et al.
HEPATOLOGY (2011)
PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice
Wei Qiu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
PUMA Induction by FoxO3a Mediates the Anticancer Activities of the Broad-Range Kinase Inhibitor UCN-01
Crissy Dudgeon et al.
MOLECULAR CANCER THERAPEUTICS (2010)
PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells
Q. Sun et al.
ONCOGENE (2009)
Chemosensitization of head and neck cancer cells by PUMA
Quanhong Sun et al.
MOLECULAR CANCER THERAPEUTICS (2007)
p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion
Bin Wu et al.
GUT (2007)
The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage
Peng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PUMA dissociates bax and bcl-XL to induce apoptosis in colon cancer cells
Lihua Ming et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
BRAF mutation predicts sensitivity to MEK inhibition
DB Solit et al.
NATURE (2006)
PUMA mediates the apoptotic response to p53 in colorectal cancer cells
J Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
